Our point of view
A guide with the labels turned outward.
Lumira is for people who search for Lumira Peptides and want to understand what they have found. These pages explain skin peptide names and point readers toward a licensed U.S. route, with its limits stated plainly.
Licensed U.S. provider review
Start Promise Peptides skin visitLumira may earn money when readers become Promise patients.
Promise prescribes GHK-Cu, Glow and KLOW now through licensed U.S. providers. A provider reviews every request and decides whether a prescription is appropriate. Not everyone qualifies. Compounded medicines are made to order. They are not approved by the U.S. Food and Drug Administration (FDA).
U.S. patients only. Availability varies by state and by treatment.
For the curious, including the first-time reader
Peptide language can sound familiar and unfamiliar at once. GHK-Cu, Glow and KLOW may appear beside skincare words, drug words or lab labels. Lumira starts by separating those meanings.
A peptide is a short chain of amino acids, the building blocks of proteins. That basic definition is useful. It is not a claim that every peptide belongs in a skincare routine or a prescription.
Readers may arrive expecting a shop. Lumira is a guide. It does not sell products, give personal medical advice or decide who qualifies for treatment.
Clarity before a conclusion
We explain what a substance is before discussing the evidence. We keep lab and animal research separate from research in people. A result involving a cream cannot answer a question about an injection.
Blend names receive the same care. An ingredient list does not prove a result for a mixture. More ingredients do not establish that a blend is better.
We state limits alongside the facts. A prescription is not approval by the U.S. Food and Drug Administration (FDA). Compounded medicines, prepared to order, are not FDA-approved. A withdrawn request for FDA review is not clearance.
Technical words get a short explanation when they first appear. The aim is to let a reader follow the question without having to learn a new vocabulary first.
See where the facts come fromWhere the links lead, and why that matters
Lumira points readers to Promise, which prescribes GHK-Cu, Glow and KLOW now through licensed U.S. providers. A provider reviews every request and decides; not everyone qualifies.
Lumira may earn money when readers become Promise patients.
That financial relationship is stated beside the first link on each page and again at the bottom. It does not change the evidence or a provider's decision. A reader can use the guide without following an outside link.
Lumira is not affiliated with any company that has used the name Lumira Peptides.
Personal questions belong in personal care
This guide explains categories and evidence. It cannot review a reader's health, medicines or personal risks. A licensed provider makes decisions about care, and a pharmacy makes its own decision about lawful preparation.
The next page is yours
Keep the licensed route in view
A visit begins a review. A licensed U.S. provider decides whether a prescription is appropriate. Not everyone qualifies, and availability varies by state and by treatment.
Licensed U.S. provider review
Start Promise skin visitLumira may earn money when readers become Promise patients.
Promise prescribes GHK-Cu, Glow and KLOW now through licensed U.S. providers. A provider is a health professional who can make prescription decisions. One reviews every request and decides whether to prescribe. Not everyone qualifies.
Medications are prepared by licensed U.S. compounding pharmacies. Compounded medications are not FDA-approved. A pharmacy separately decides whether it can lawfully prepare a prescription.
U.S. patients only. Availability varies by state and by treatment.
Promise is LegitScript-certified. That certification is not FDA approval.